NEW YORK (GenomeWeb) – Affymetrix reported after the close of the market Wednesday that its fourth quarter revenues increased 2 percent year over year, beating the consensus Wall Street estimate.

The Santa Clara, California-based microarray and genetic analysis products firm reported total revenues of $95.6 million for the quarter ended Dec. 31, 2015, up from $93.5 million in Q4 2014 and beating analysts' consensus estimate of $93.3 million. On a constant currency basis, Affy said its Q4 2015 revenues were up nearly 7 percent year over year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.